GreenLight Biosciences Holdings Probability of Future Stock Price Finishing Over 0.0275
| GRNAWDelisted Stock | USD 0.02 0 25.00% |
GreenLight |
GreenLight Biosciences Target Price Odds to finish over 0.0275
The tendency of GreenLight Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 0.03 or more in 90 days |
| 0.02 | 90 days | 0.03 | about 45.7 |
Based on a normal probability distribution, the odds of GreenLight Biosciences to move over $ 0.03 or more in 90 days from now is about 45.7 (This GreenLight Biosciences Holdings probability density function shows the probability of GreenLight Stock to fall within a particular range of prices over 90 days) . Probability of GreenLight Biosciences price to stay between its current price of $ 0.02 and $ 0.03 at the end of the 90-day period is about 19.38 .
Assuming the 90 days horizon GreenLight Biosciences has a beta of 0.47. This usually indicates as returns on the market go up, GreenLight Biosciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding GreenLight Biosciences Holdings will be expected to be much smaller as well. Additionally GreenLight Biosciences Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. GreenLight Biosciences Price Density |
| Price |
Predictive Modules for GreenLight Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GreenLight Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.GreenLight Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. GreenLight Biosciences is not an exception. The market had few large corrections towards the GreenLight Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold GreenLight Biosciences Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of GreenLight Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.05 | |
β | Beta against Dow Jones | 0.47 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | -0.0064 |
GreenLight Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of GreenLight Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for GreenLight Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| GreenLight Biosciences is not yet fully synchronised with the market data | |
| GreenLight Biosciences has some characteristics of a very speculative penny stock | |
| GreenLight Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 6.38 M. Net Loss for the year was (167.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| GreenLight Biosciences Holdings has accumulated about 34.75 M in cash with (136.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
GreenLight Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of GreenLight Stock often depends not only on the future outlook of the current and potential GreenLight Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GreenLight Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 132 B | |
| Cash And Short Term Investments | 68.1 M |
GreenLight Biosciences Technical Analysis
GreenLight Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. GreenLight Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of GreenLight Biosciences Holdings. In general, you should focus on analyzing GreenLight Stock price patterns and their correlations with different microeconomic environments and drivers.
GreenLight Biosciences Predictive Forecast Models
GreenLight Biosciences' time-series forecasting models is one of many GreenLight Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary GreenLight Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about GreenLight Biosciences
Checking the ongoing alerts about GreenLight Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for GreenLight Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| GreenLight Biosciences is not yet fully synchronised with the market data | |
| GreenLight Biosciences has some characteristics of a very speculative penny stock | |
| GreenLight Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 6.38 M. Net Loss for the year was (167.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| GreenLight Biosciences Holdings has accumulated about 34.75 M in cash with (136.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in GreenLight Stock
If you are still planning to invest in GreenLight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GreenLight Biosciences' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |